Cognition Therapeutics, Inc.
CGTXNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $66.39M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.55$2.00
- Volume (live)
- -
- Avg. volume (3M)
- 534.29K
Cognition Therapeutics (CGTX) Stock Price & Financial Analysis
Cognition Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.71 - $0.79 |
|---|---|
| 52-Week High | $2.00 |
| 52-Week Low | $0.55 |
| Open | $0.76 |
| Volume (last close) | 420.60K |
| Average Volume (3M) | 534.29K |
| 50-Day MA | $0.99 |
|---|---|
| 200-Day MA | $1.11 |
| 1-Year Change | −57.90% |
| Market Cap | 66.39M |
|---|---|
| Shares Outstanding | 90.62M |
| Price to Book (P/B) | 2.01 |
| EV/EBITDA | -1.47 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Cognition Therapeutics at a Glance
As of the Oct 16, 2026 close, Cognition Therapeutics (CGTX) has a market capitalization of $66.39M.
As of its latest reported balance sheet, it holds $34.01M in cash and securities against $500.00K of debt, a net cash position of $33.51M.
Cognition Therapeutics does not currently pay a dividend.
The share price is down 57.9% over the past year. At $0.73 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.55 to $2.00, below its 200-day moving average of $1.11.
Frequently Asked Questions About Cognition Therapeutics
What is the current stock price for CGTX?
As of the Oct 16, 2026 close, CGTX stock trades at $0.73. The 52-week range is $0.55–$2.00, with a day range of $0.71–$0.79.
What is the P/E ratio for CGTX?
The P/E ratio (Price-to-Earnings) for CGTX is shown in the Key Statistics section. This valuation metric helps compare Cognition Therapeutics, Inc. to industry peers.
Does CGTX pay dividends?
Cognition Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CGTX?
Analyst ratings and recommendations for CGTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CGTX?
As of the Oct 16, 2026 close, Cognition Therapeutics's market capitalization is $66.1M, classifying it as a micro-cap company. Cognition Therapeutics operates in the Healthcare sector within the Biotechnology industry.